Taiwo Oladapo

Array ( [id] => 6626699 [patent_doc_number] => 20100172901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Polymorphisms in the EGFR Pathway as Markers for Cancer Treatment' [patent_app_type] => utility [patent_app_number] => 12/523517 [patent_app_country] => US [patent_app_date] => 2008-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 29691 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172901.pdf [firstpage_image] =>[orig_patent_app_number] => 12523517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228855 [patent_doc_number] => 20100183593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Gene Polymorphisms Predictive for Dual TKI Therapy' [patent_app_type] => utility [patent_app_number] => 12/523514 [patent_app_country] => US [patent_app_date] => 2008-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22663 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183593.pdf [firstpage_image] =>[orig_patent_app_number] => 12523514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 243026 [patent_doc_number] => 07588760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-15 [patent_title] => 'Antagonists specific for denatured collagen and methods of using same' [patent_app_type] => utility [patent_app_number] => 12/016048 [patent_app_country] => US [patent_app_date] => 2008-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 16376 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/588/07588760.pdf [firstpage_image] =>[orig_patent_app_number] => 12016048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904656 [patent_doc_number] => 20080114070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'COMPOSITIONS AND METHODS FOR RESTORING SENSITIVITY OF TUMOR CELLS TO ANTITUMOR THERAPY AND INDUCING APOPTOSIS' [patent_app_type] => utility [patent_app_number] => 11/970881 [patent_app_country] => US [patent_app_date] => 2008-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13132 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20080114070.pdf [firstpage_image] =>[orig_patent_app_number] => 11970881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4832901 [patent_doc_number] => 20080131448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'CANCER IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 11/970401 [patent_app_country] => US [patent_app_date] => 2008-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17855 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131448.pdf [firstpage_image] =>[orig_patent_app_number] => 11970401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6247172 [patent_doc_number] => 20100136576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'In Vitro Method for Diagnosing Prostate Cancer' [patent_app_type] => utility [patent_app_number] => 12/522290 [patent_app_country] => US [patent_app_date] => 2008-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9934 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136576.pdf [firstpage_image] =>[orig_patent_app_number] => 12522290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6576661 [patent_doc_number] => 20100047242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS CAPABLE OF INDUCING APOPTOSIS IN TUMOUR CELLS, USEFUL FOR DIAGNOSIS AND TREATMENT OF B-CHRONIC LYMPHOCYTIC LEUKAEMIA' [patent_app_type] => utility [patent_app_number] => 12/525449 [patent_app_country] => US [patent_app_date] => 2007-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2289 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047242.pdf [firstpage_image] =>[orig_patent_app_number] => 12525449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6492664 [patent_doc_number] => 20100093626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'PEPTIDE AND SMALL MOLECULE AGONISTS OF EPHA AND THEIR USES IN DISEASE' [patent_app_type] => utility [patent_app_number] => 12/519294 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22416 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093626.pdf [firstpage_image] =>[orig_patent_app_number] => 12519294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 44425 [patent_doc_number] => 07777004 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'Polypeptides comprising Fas activation and NKG2D-ligand domains' [patent_app_type] => utility [patent_app_number] => 11/945747 [patent_app_country] => US [patent_app_date] => 2007-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 13420 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/777/07777004.pdf [firstpage_image] =>[orig_patent_app_number] => 11945747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4807466 [patent_doc_number] => 20080171044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING SQUAMOUS CELL CARCINOMA' [patent_app_type] => utility [patent_app_number] => 11/943486 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 19429 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171044.pdf [firstpage_image] =>[orig_patent_app_number] => 11943486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765819 [patent_doc_number] => 20080177031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/985028 [patent_app_country] => US [patent_app_date] => 2007-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8645 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20080177031.pdf [firstpage_image] =>[orig_patent_app_number] => 11985028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6483202 [patent_doc_number] => 20100008930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'METHOD FOR THE DIAGNOSIS OF LEUKEMIA' [patent_app_type] => utility [patent_app_number] => 12/514113 [patent_app_country] => US [patent_app_date] => 2007-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6946 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20100008930.pdf [firstpage_image] =>[orig_patent_app_number] => 12514113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5309749 [patent_doc_number] => 20090017030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Endothelial Cell Expression Patterns' [patent_app_type] => utility [patent_app_number] => 11/930528 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21349 [patent_no_of_claims] => 86 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017030.pdf [firstpage_image] =>[orig_patent_app_number] => 11930528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4866800 [patent_doc_number] => 20080145859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Diagnosis and treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/980978 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 29112 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145859.pdf [firstpage_image] =>[orig_patent_app_number] => 11980978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813859 [patent_doc_number] => 20080194490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'AT4 RECEPTOR LIGANDS AS ANGIOGENIC, ANTI-ANGIOGENIC, AND ANTI-TUMOR AGENTS' [patent_app_type] => utility [patent_app_number] => 11/929205 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 3849 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194490.pdf [firstpage_image] =>[orig_patent_app_number] => 11929205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6625679 [patent_doc_number] => 20100172837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'MN Gene and Protein' [patent_app_type] => utility [patent_app_number] => 11/930055 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 30137 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172837.pdf [firstpage_image] =>[orig_patent_app_number] => 11930055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867559 [patent_doc_number] => 20080146618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'CA IX-Specific Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/929750 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 28455 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146618.pdf [firstpage_image] =>[orig_patent_app_number] => 11929750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4759946 [patent_doc_number] => 20080312172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Anti-IL-6 Antibodies, Compositions, Methods and Uses' [patent_app_type] => utility [patent_app_number] => 11/927925 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 32279 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312172.pdf [firstpage_image] =>[orig_patent_app_number] => 11927925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 81243 [patent_doc_number] => 07745148 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Random homozygous gene perturbation to enhance antibody production' [patent_app_type] => utility [patent_app_number] => 11/928393 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 5084 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745148.pdf [firstpage_image] =>[orig_patent_app_number] => 11928393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616479 [patent_doc_number] => 20100003247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'ASSAY FOR METASTATIC COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 12/446910 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9265 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003247.pdf [firstpage_image] =>[orig_patent_app_number] => 12446910 [rel_patent_id] =>[rel_patent_doc_number] =>)